Literature DB >> 12520705

Peritoneal involvement in stage II colon cancer.

A M Lennon1, H E Mulcahy, J M P Hyland, C Lowry, A White, D Fennelly, J J Murphy, D P O'Donoghue, K Sheahan.   

Abstract

A pathologist (K.S.) reviewed histologic slides for peritoneal involvement by tumor cells for 118 patients with stage II colon cancer. Patients were followed up for a median of 6 years. Tumor cells were found free in the peritoneal space in 16 cases (13.6%). The presence of cancer cells free in the peritoneal space was associated with lymphovascular invasion (P = .001) and neural invasion (P < .001). The overall 5-year survival was 80% in the patient population, but was 39% and 86% for those with and without tumor cells free in the peritoneal space, respectively (P < .0001). Multivariate analysis confirmed that free tumor cells within the peritoneal space (P < .0001) and lymphovascular invasion (P = .007) were related independently to outcome. Peritoneal involvement with tumor cells free in the peritoneal space in stage II colon cancer is a powerful indicator of outcome; patients have a survival similar to that for patients with stage III disease.

Entities:  

Mesh:

Year:  2003        PMID: 12520705     DOI: 10.1309/J6BD-TWM2-M792-TN2V

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.

Authors:  Edward J Fox; Dermot T Leahy; Robert Geraghty; Hugh E Mulcahy; David Fennelly; John M Hyland; Diarmuid P O'Donoghue; Kieran Sheahan
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  Rectal cancer presenting with synchronous intraperitoneal spread of disease.

Authors:  Andrew Leiker; Gaurav Khatri; Jeffrey Meyer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-03-15

Review 3.  Controversies in the pathological assessment of colorectal cancer.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Prognostic biomarkers in colorectal cancer: where do we stand?

Authors:  Xavier Sagaert
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

5.  Carcinoma obstruction of the proximal colon cancer and long-term prognosis--obstruction is a predictor of worse outcome in TNM stage II tumor.

Authors:  Chih-Chien Chin; Jeng-Yi Wang; Chung-Rong Changchien; Wen-Shih Huang; Reiping Tang
Journal:  Int J Colorectal Dis       Date:  2010-02-05       Impact factor: 2.571

Review 6.  Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer.

Authors:  Paul H Sugarbaker
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

7.  Dual Energy Spectral CT Imaging for Colorectal Cancer Grading: A Preliminary Study.

Authors:  Hong-Xia Gong; Ke-Bei Zhang; Lian-Ming Wu; Brian F Baigorri; Yan Yin; Xiao-Chuan Geng; Jian-Rong Xu; Jiong Zhu
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

8.  Molecular detection (k-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer?

Authors:  Annette Torgunrud Kristensen; Johan N Wiig; Stein G Larsen; Karl-Erik Giercksky; Per O Ekstrøm
Journal:  BMC Cancer       Date:  2008-07-27       Impact factor: 4.430

9.  Assessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and Criticisms.

Authors:  Colin J R Stewart; Simon Hillery; Cameron Platell; Giacomo Puppa
Journal:  Cancers (Basel)       Date:  2011-01-04       Impact factor: 6.639

Review 10.  Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.

Authors:  Hang Yuan; Quanjin Dong; Bo'an Zheng; Xinye Hu; Jian-Bo Xu; Shiliang Tu
Journal:  Oncotarget       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.